Expanding health technology assessment towards broader value: Ireland as a case study

被引:4
作者
Kinchin, Irina [1 ]
Walshe, Valerie [2 ]
Normand, Charles [1 ]
Coast, Joanna [3 ]
Elliott, Rachel [4 ]
Kroll, Thilo [5 ]
Kinghorn, Philip [6 ]
Thompson, Alexander [4 ]
Viney, Rosalie [7 ]
Currow, David [8 ]
O'Mahony, James F. [1 ]
机构
[1] Univ Dublin, Trinity Coll Dublin, Ctr Hlth Policy & Management, Dublin, Ireland
[2] Hlth Serv Execut, Dublin, Ireland
[3] Univ Bristol, Bristol Populat Hlth Sci Inst, Bristol, England
[4] Univ Manchester, Manchester Ctr Hlth Econ, Manchester, England
[5] Univ Coll Dublin, Sch Nursing Midwifery & Hlth Syst, Dublin, Ireland
[6] Univ Birmingham, Inst Appl Hlth Res, Hlth Econ Unit, Birmingham, England
[7] Univ Technol Sydney, Ctr Hlth Econ Res & Evaluat CHERE, Ultimo, NSW, Australia
[8] Univ Wollongong, Fac Sci Med & Hlth, Wollongong, NSW, Australia
关键词
Health technology assessment (HTA); resource allocation; outcome measurement; benefits beyond health; wellbeing; social value; INVOLVEMENT; FRAMEWORK; PATIENT; QALYS; EXTRA; HTA;
D O I
10.1017/S0266462323000235
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Healthcare innovations often represent important improvements in population welfare, but at what cost, and to whom? Health technology assessment (HTA) is a multidisciplinary process to inform resource allocation. HTA is conventionally anchored on health maximization as the only relevant output of health services. If we accept the proposition that health technologies can generate value outside the healthcare system, resource allocation decisions could be suboptimal from a societal perspective. Incorporating "broader value" in HTA as derived from social values and patient experience could provide a richer evaluative space for informing resource allocation decisions. This article considers how HTA is practiced and what its current context implies for adopting "broader value" to evaluating health technologies. Methodological challenges are highlighted, as is a future research agenda. Ireland serves as an example of a healthcare system that both has an explicit role for HTA and is evolving under a current program of reform to offer universal, single-tier access to public services. There are various ways in which HTA processes could move beyond health, including considering the processes of care delivery and/or expanding the evaluative space to some broader concept of well-being. Methods to facilitate the latter exist, but their adaptation to HTA is still emerging. We recommend a multi-stakeholder working group to develop and advance an international agenda for HTA that captures welfare/benefit beyond health.
引用
收藏
页数:7
相关论文
共 39 条
[1]   PUBLIC AND PATIENT INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT: A FRAMEWORK FORACTION [J].
Abelson, Julia ;
Wagner, Frank ;
DeJean, Deirdre ;
Boesveld, Sarah ;
Gauvin, Francois-Pierre ;
Bean, Sally ;
Axler, Renata ;
Petersen, Stephen ;
Baidoobonso, Shamara ;
Pron, Gaylene ;
Giacomini, Mita ;
Lavis, John .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2016, 32 (04) :256-264
[2]   The representation of public values in health technology assessment to inform funding decisions: the case of Australia's national funding bodies [J].
Afzali, Hossein Haji Ali ;
Street, Jackie ;
Merlin, Tracy ;
Karnon, Jonathan .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2021, 37 (01)
[3]  
[Anonymous], CONVERSION RATE GBP
[4]   Valuing the benefits and costs of health care programmes: where's the 'extra' in extra-welfarism? [J].
Birch, S ;
Donaldson, C .
SOCIAL SCIENCE & MEDICINE, 2003, 56 (05) :1121-1133
[5]   Improving Cross-Sector Comparisons: Going Beyond the Health-Related QALY [J].
Brazier, John ;
Tsuchiya, Aki .
APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2015, 13 (06) :557-565
[6]   Welfarism vs. extra-welfarism [J].
Brouwer, Werner B. F. ;
Culyer, Anthony J. ;
van Exel, N. Job A. ;
Rutten, Frans F. H. .
JOURNAL OF HEALTH ECONOMICS, 2008, 27 (02) :325-338
[7]  
Canadian Agency for Drugs and Technologies in Health (CADTH), GUID EC EV HLTH TECH, P201
[8]  
Claxton K., 2010, Appropriate Perspectives for Health Care Decisions
[9]   Conceptualising 'Benefits Beyond Health' in the Context of the Quality-Adjusted Life-Year: A Critical Interpretive Synthesis [J].
Engel, Lidia ;
Bryan, Stirling ;
Whitehurst, David G. T. .
PHARMACOECONOMICS, 2021, 39 (12) :1383-1395
[10]   Patient and public involvement in health technology assessment: update of a systematic review of international experiences [J].
Gagnon, Marie-Pierre ;
Dipankui, Mylene Tantchou ;
Poder, Thomas G. ;
Payne-Gagnon, Julie ;
Mbemba, Gisele ;
Beretta, Valentina .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2021, 37 (01)